|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Zinc oxide nano-enabled microfluidic reactor for water purification and its applicability to volatile organic compounds显示文摘This paper reports fast and efficient chemical decontamination of water within a tree-branched centimeter-scale microfluidic reactor.The microreactor integrates Zinc oxide nanowires(ZnO NWs)in situ grown acting as an efficient photocatalytic nanomaterial layer.Direct growth of ZnO NWs within the microfluidic chamber brings this photocatalytic medium at the very close vicinity of the water flow path,hence minimizing the required interaction time to produce efficient purification performance.We demonstrate a degradation efficiency of 95%in o5 s of residence time in one-pass only.According to our estimates,it becomes attainable using microfluidic reactors to produce decontamination of merely 1 l of water per day,typical of the human daily drinking water needs.To conduct our experiments,we have chosen a laboratory-scale case study as a seed for addressing the health concern of water contamination by volatile organic compounds(VOCs),which remain difficult to remove using alternative decontamination techniques,especially those involving water evaporation.The contaminated water sample contains mixture of five pollutants:Benzene;Toluene;Ethylbenzene;m–p Xylenes;and o-Xylene(BTEX)diluted in water at 10 p.p.m.concentration of each.Degradation was analytically monitored in a selective manner until it falls below 1 p.p.m.for each of the five pollutants,corresponding to the maximum contaminant level(MCL)established by the US Environmental Protection Agency(EPA).We also report on a preliminary study,investigating the nature of the chemical by-products after the photocatalytic VOCs degradation process. | Imadeddine Azzouz Yamina Ghozlane Habba Martine Capochichi-Gnambodoe Frédéric Marty Jérôme Vial Yamin Leprince-Wang Tarik Bourouina | 2018 | Microsystems & Nanoengineering2018，4，1： | 4 |
| 2 | Effect of Ebo- la progression on transmission and control in liberia显示文摘 | Yamin D Gertler S Ndeffo-Mbah M L | 2015 | Ann Intern Med2015，162，1： | 1 |
| 3 | Cost-effec- tiveness of influenza vaccination in prior pneumonia pa- tients in Israel显示文摘 | YAMIN D BALICER R D GALVANI A P | 2014 | Vaccine2014，32，33： | 1 |
| 4 | Factors Associated with In-stent Restenosis in Patients Following Percuta- neous Coronary Intervention显示文摘 | Wihanda D Alwi 1 Yamin M | 2015 | Acta Med Indones2015，47，3： | 1 |
| 5 | The correlation between charge/discharge rates and morphology, surface chemistry, and performance of Li electrodes and the connection to cycle life of practical batteries显示文摘 | D Aurbach I Weissman H Yamin | 1998 | J Electrochem Soc1998，145，5： | 1 |
| 6 | The dependence of the performance of Li-C intercalation anodes for Li-ion secondary batteries on the electrolyte solution composition显示文摘 | EIN-ELI Y MARKOVSKY B AURBACH D CARMELI Y YAMIN H LUSKI S | 1994 | Electomchimica Acta1994，39，17： | 1 |
| 7 | Comparison of linear scheduling model(LSM) and critical path method(CPM) 显示文摘 | Yamin R A Harmelink D J | 2001 | Journal of Construction Engineering and Manage- ment2001，127，5： | 1 |
| 8 | Incentives' effect in influenza vaccination policy 显示文摘 | Yamin D Gavious A | 2013 | Management Science2013，59，12： | 1 |
| 9 | The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation 显示文摘 | Yamin T T Miller D K | 1997 | J Biol Chem1997，272，21： | 1 |
| 10 | Growing urban roads 显示文摘 | Yamins D Rasmussen S Fogel D | 2003 | Networks and Spatial Economics2003，3，1： | 1 |
| 11 | Growing urban roads显示文摘 | Yamins D Rasmussen S Fogel D | 2003 | Networks and Spatial Economics2003，3，： | 1 |
| 12 | A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease显示文摘AIM To evaluate the novel platelet-derived growth factor receptor and vascular endothelial growth factor receptor dual kinase inhibitor ANG3070 in a polycystic kidney disease-congenital hepatic fibrosis model.METHODS At 6 wk of age, PCK rats were randomized to vehicle or ANG3070 for 4 wk. At 10 wk, 24 h urine and left kidneys were collected and rats were continued on treatment for 4 wk. At 14 wk, 24 h urine was collected, rats were sacrificed, and liver and right kidneys were collected for histological evaluation. For Western blot studies, PCK rats were treated with vehicle or ANG3070 for 7 d and sacrificed approximately 30 min after the last treatments.RESULTS Compared to the wild-type cohort, the PCK kidney(Vehicle cohort) exhibited a marked increase in kidney and liver mass, hepato-renal cystic volume, hepato-renal fibrosis and hepato-renal injury biomarkers. Intervention with ANG3070 in PCK rats decreased kidney weight, reduced renal cystic volume and reduced total kidney hydroxyproline, indicating significantly reduced rental interstitial fibrosis compared to the PCK-Vehicle cohort. ANG3070 treatment also mitigated several markers of kidney injury, including urinary neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, cystatin C and interleukin-18 levels. In addition, this treatment attenuated key indices of renal dysfunction, including proteinuria, albuminuria and serum blood urea nitrogen and creatinine, and significantly improved renal function compared to the PCK-Vehicle cohort. ANG3070 treatment also significantly decreased liver enlargement, hepatic lesions, and liver fibrosis, and mitigated liver dysfunction compared to the PCK-Vehicle cohort.CONCLUSION These results suggest that ANG3070 has the potential to slow disease, and may serve as a bridge toward hepato-renal transplantation in patients with fibropolycystic disease. | Prani Paka Brian Huang Bin Duan Jing-Song Li Ping Zhou Latha Paka Michael A Yamin Scott L Friedman Itzhak D Goldberg Prakash Narayan | 2018 | World Journal of Nephrology2018，7，5： | 1 |
| 13 | Comparison of linear scheduling model (LSM) and critical path method (CPM)显示文摘 | Yamin R A Harmelink D J | 2001 | Journal of Construction Engineering and Management2001，127，5： | 1 |
| 14 | Factors associated with in-stent restenosisin patients following percutaneous coronary intervention显示文摘 | Wihanda D Alwi I Yamin M | 2015 | Acta Med Indones2015，47，3： | 1 |
| 15 | The correlation between charge/discharge rates and morphology, surface chemistry, and performance of Li electrodes and the connection to cycle life of practical batterie显示文摘 | AURBACH D WEISSMAN I YAMIN H | 1998 | J Electrochem Soc1998，145，5： | 1 |
| 16 | The correlation between charge/discharge rates and morphology,surface chemistry,and performance of Li electrodes and the connection to cycle Life of practical batteries显示文摘 | Aurbach D Weissman I Yamin H | 1998 | Electrochem Soc1998，145，5： | 1 |
| 17 | Factors Associated with Instent Restenosis in Patients Following Percutaneous Coronary Intervention显示文摘 | Wihanda D Alwi I Yamin M | 2015 | Acta Medica Indonesiana2015，47，3： | 1 |
| 18 | Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease显示文摘AIM To evaluate a calcium activated potassium channel(KCa3.1) inhibitor attenuates liver disease in models of non-alcoholic fatty liver disease(NAFLD).METHODS We have performed a series of in vitro and in vivo studies using the KCa3.1 channel inhibitor, Senicapoc. Efficacy studies of Senicapoc were conducted in toxin-, thioacetamide(TAA) and high fat diet(HFD)-induced models of liver fibrosis in rats. Efficacy and pharmacodynamic effects of Senicapoc was determined through biomarkers of apoptosis, inflammation, steatosis and fibrosis. RESULTS Upregulation of KCa3.1 expression was recorded in TAA-induced and high fat diet-induced liver disease. Treatment with Senicapoc decreased palmitic aciddriven Hep G2 cell death.(P < 0.05 vs control) supporting the finding that Senicapoc reduces lipiddriven apoptosis in Hep G2 cell cultures. In animals fed a HFD for 6 wk, co-treatment with Senicapoc,(1) reduced non-alcoholic fatty liver disease(NAFLD) activity score(NAS)(0-8 scale),(2) decreased steatosis and(3) decreased hepatic lipid content(Oil Red O, P < 0.05 vs vehicle). Randomization of TAA animals and HFD fed animals to Senicapoc was associated with a decrease in liver fibrosis as evidenced by hydroxyproline and Masson's trichrome staining(P < 0.05 vs vehicle). These results demonstrated that Senicapoc mitigates both steatosis and fibrosis in liver fibrosis models.CONCLUSION These data suggest that Senicapoc interrupts more than one node in progressive fatty liver disease by its anti-steatotic and anti-fibrotic activities, serving as a double-edged therapeutic sword. | latha paka david e smith dawoon jung siobhan mccormack ping zhou bin duan jing-song li jiaqi shi yong-jie hao kai jiang michael yamin itzhak d goldberg prakash narayan | 2017 | World Journal of Gastroenterology2017，23，23： | 1 |
| 19 | Growing urban roads显示文摘 | Yamins D Rasmussen S Fogel D | 2003 | Networks and Spatial Economics2003，3，1： | 1 |
| 20 | Comparison of Linear Scheduling Model(LSM) and Critical Path Method(CPM)显示文摘 | Harmelink D J Yamin R A | | 0，，05： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员